At a glance
| What it is | Synthetic peptide used in anti-aging and eye-care skincare, best known by the trade name Eyeseryl |
| Main uses | Marketed mainly to reduce the appearance of under-eye puffiness and bags, through a proposed anti-edema and anti-glycation action |
| FDA status | Cosmetic ingredient rather than a drug, so does not require FDA approval |
| Evidence strength | Low research |
What is acetyl tetrapeptide-5?
Acetyl tetrapeptide-5 is a synthetic peptide of four amino acids used as a cosmetic ingredient, best known by the trade name Eyeseryl, developed by the ingredient maker Lipotec, now part of Lubrizol. It is a small "signal" peptide, meaning it is designed to interact with skin biology rather than simply sit on the surface, and it is sold almost exclusively in products aimed at the under-eye area. It is applied topically, usually in eye creams, serums, and gels marketed to reduce the look of puffiness and bags.
How does it work?
Acetyl tetrapeptide-5 is thought to reduce the appearance of under-eye bags through two proposed actions:
- An anti-edema effect. Puffiness under the eyes is partly caused by fluid pooling in the tissue, and in the manufacturer's testing the peptide reduced that fluid buildup, in part by lowering the leakiness of small blood vessels, their vascular permeability, so that less fluid escapes into the surrounding skin.
- An effect on glycation, the process in which sugars bind to and stiffen collagen. By limiting glycation, the peptide is proposed to help the thin skin under the eyes stay more elastic and less prone to the slackening that deepens the look of bags.
Both of these are findings from laboratory and manufacturer studies rather than independent clinical research. As with any topical peptide, how much of it actually crosses the skin barrier to reach the tissue underneath is uncertain, and that places a ceiling on how strong the effect can be.
Is it FDA-approved?
No, and it does not need to be. The FDA does not approve cosmetics or most cosmetic ingredients before they go on the market. Cosmetics must be safe when used as directed and properly labeled, but there is no pre-market approval step the way there is for drugs, so no de-puffing or anti-aging peptide in a serum is "FDA-approved." The distinction that matters for an ingredient like this is the line between a cosmetic and a drug. A product is a cosmetic when it is intended to improve appearance, but if it claims to change the structure or function of the body, the FDA can regulate it as an unapproved drug. This is why de-puffing claims are written around the appearance of the under-eye area rather than a promised physiological change.
What is it used for?
Acetyl tetrapeptide-5 is used almost entirely in topical eye-care products, where it is included to reduce the appearance of under-eye puffiness, bags, and swelling. It often appears alongside ingredients such as caffeine or hyaluronic acid in eye creams, serums, and gels, and some formulas also position it as helping the under-eye skin look firmer and smoother.
What does the research show?
The published evidence for acetyl tetrapeptide-5 is thin and comes mostly from its manufacturer. Lipotec's own panel studies report a visible reduction in the appearance of under-eye bags and puffiness in volunteers who used a formulation containing the peptide, but those results have not been reproduced in independent, peer-reviewed clinical trials. So while the proposed mechanism is reasonable and the manufacturer data is encouraging, the cosmetic benefit rests largely on the company's own testing rather than on strong outside evidence.
What are the side effects?
Topical acetyl tetrapeptide-5 is generally considered well tolerated, with the low potential for irritation typical of cosmetic peptides, and it is used on the especially delicate skin around the eyes. As with any skincare ingredient, some people can still experience mild redness, stinging, or an allergic reaction, so patch testing before regular use and keeping the product out of the eyes themselves is sensible.
Evidence strength
Low research: Its human evidence is limited mainly to manufacturer panel studies, with no independent, peer-reviewed clinical trial, so the cosmetic benefit is largely unverified despite a plausible anti-edema mechanism.
Sources: mechanism and efficacy claims are drawn from the ingredient manufacturer (Lipotec/Lubrizol, Eyeseryl) and ingredient references such as INCIDecoder; regulatory framing from FDA guidance on how cosmetics are regulated. This document is educational and does not constitute medical advice or a treatment claim.
Heart & Vascular Health
Metabolic Health
Energy
Liver Health
Kidney
Sex Hormones
Thyroid Health
Nutrients
Immune System
Inflammation